InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by Thompson Craig B.. Director active across 2 companies, notably Regeneron Pharmaceuticals, INC.. Aggregated, 9 disclosures have been recorded. Activity tracked since 3 October 2022. The latest transaction was filed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
9 条申报中的 9 条
Thompson Craig B. is a declarant and has 9 filings in total. In the 9 sampled filings, the buy and sell amounts are 0, the period runs from 2022-10-05 to 2026-01-06, and the companies mentioned are Regeneron Pharmaceuticals, INC. and Charles River Laboratories International, INC., where he is a Director.